NCT00551447已完成3 期
A Comparison of Treatment With Ezetimibe (SCH 58235) and Simvastatin Coadministration Versus Simvastatin in Attaining the National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP) III Coronary Heart Disease (CHD) or CHD Risk Equivalent Strata Low-Density Lipoprotein Cholesterol (LDL-c)
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 616
- 主要终点
- LDL-C measurement (target goal = <100 mg/dL)
研究概览
简要总结
This purpose of this study is to determine if the administration of ezetimibe and simvastatin together is more effective than simvastatin alone in lowering LDL-C levels to a goal of <100 mg/dL in patients at risk for Heart Disease.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Men and women aged 18 to 80 at risk for Heart Disease who have LDL-C levels greater than or equal to 130 mg/dL and triglyceride level less than or equal to 350 mg/dL
- •Patients must be able to maintain the National Cholesterol Education Program diet throughout the course of the study
排除标准
- •Patients are excluded from the study if their weight is less than 50% of ideal body weight, if they are pregnant or lactating, have congestive heart failure, uncontrolled heart rhythm problems or a recent heart attack, coronary artery bypass surgery, or angioplasty. Additionally, patients with poorly controlled Type 1 or 2 diabetes mellitus, kidney disease, uncontrolled endocrine or metabolic disease, are known HIV positive, and uncontrolled high blood pressure
结局指标
主要结局
LDL-C measurement (target goal = <100 mg/dL)
时间窗: 27 Weeks
次要结局
- Well tolerated in patients(27 Weeks)
研究者
相似试验
已完成
3 期
Effect of Ezetimibe Plus Simvastatin Versus Simvastatin Alone on Atherosclerosis in the Carotid Artery (ENHANCE)(P02578)Hyperlipoproteinemia Type IIAtherosclerosisHypercholesterolemiaNCT00552097Organon and Co720
终止
3 期
Effect of Ezetimibe Plus Simvastatin on Flow-Mediated Brachial Artery Vasoactivity in Subjects With Primary Hypercholesterolemia (Study P03336)AtherosclerosisHypercholesterolemiaNCT00651391Organon and Co28
已完成
4 期
The PostprAndial eNdothelial Function After Combination of Ezetimibe and simvAstatin StudyMetabolic SyndromeNCT00817843dr.Frank L.J. Visseren100
已完成
4 期
Ezetimibe Plus Simvastatin Versus Simvastatin in Untreated Subjects With High Cholesterol (P03435)HypercholesterolaemiaAtherosclerosisNCT00653835Organon and Co153
已完成
4 期
Ezetimibe and Statins on Postprandial Lipemia in Type 2 DiabetesPostprandial LipemiaType 2 DiabetesNCT00699023Federico II University13